Marshall Wace
ETNB

Marshall Wace’s 89bio ETNB Stock Holding History

Marshall Wace’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-554,337
Closed -$6.19M – 2542
2023
Q4 		$6.19M Sell
554,337
-616,419
-53% -$5.67M 0.01% 834
2023
Q3 		$18.1M Sell
1,170,756
-915,286
-44% -$15.4M 0.04% 470
2023
Q2 		$39.5M Buy
2,086,042
+956,571
+85% +$16.8M 0.08% 274
2023
Q1 		$17.2M Sell
1,129,471
-357,840
-24% -$4.67M 0.04% 519
2022
Q4 		$18.9M Buy
1,487,311
+1,037,931
+231% +$9.34M 0.04% 472
2022
Q3 		$2.6M Buy
449,380
+299,838
+201% +$1.32M 0.01% 1841
2022
Q2 		$482K Buy
+149,542
New +$451K ﹤0.01% 2805
2020
Q4 		– Sell
-33,165
Closed -$851K – 1948
2020
Q3 		$851K Buy
+33,165
New +$1.05M 0.01% 1081

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Marshall Wace's ETNB Position: Q1 2024 in Review

Marshall Wace sold out of 89bio (ETNB) in Q1 2024, closing a stake of 554,337 shares — an estimated $6.19M sold.

Marshall Wace first reported a position in ETNB in Q3 2020 and held it in 8 quarters. The position peaked at $39.5M in Q2 2023. 150 funds tracked by Wall St. Rank hold ETNB as of Q1 2024.

  • Marshall Wace reported no remaining 89bio position as of Q1 2024 after selling out during the quarter.
  • Marshall Wace sold 554,337 89bio shares in Q1 2024, an estimated $6.19M.
  • Marshall Wace first reported a position in 89bio in Q3 2020 and held it in 8 quarters.
  • Marshall Wace's 89bio position peaked at $39.5M in Q2 2023.
  • 150 funds tracked by Wall St. Rank held 89bio as of Q1 2024.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.